Nick Sullivan

Board Advisor

Nick joined the board as an adviser following the acquisition of BresMed by Arsenal Capital Partners in February 2020.

Nick is Senior Vice President of Arsenal Capital Partners’ Value Demonstration Platform. Nick provides acquired companies with the support they need to achieve success in their next chapter and as integral parts of the overall enterprise.

Nick has spent most of his career in value and access consulting, beginning two decades ago with pioneering independent firm the Total Healthcare Group. Most recently, Nick was on the executive team at Evidera as Senior Vice President of Market Access, leading teams of ~80 experts. Nick was part of the group that led the creation of Evidera from United BioSource Corporation with the support of a leading private equity firm.

Nick studied Zoology at the University of Wales, before a master’s degree at the London School of Hygiene and Tropical Medicine.

Nick is based in the Brecon Beacons, south east Wales, where he enjoys spending as much time outside, cycling, walking and learning how to garden.

What Nick says about BresMed: “I’ve admired BresMed from the outside as a competitor for many years. It’s now a privilege to be part of the family and seeing great people and cutting-edge science do great things for their clients.”

Curriculum vitae

Employment history

2020-Present   Board Advisor   BresMed

2020-Present   Senior Vice President   Arsenal Capital Partners’ Value Demonstration Platform

2016-2018   Senior Vice President, Market Access & Medical Writing  Evidera, a PPD Company

2014-2016   Senior Vice President, Market Access   Evidera, a Symphony Technology Group Company

2013-2014   Senior Vice President, Payer Communications   Evidera, a Symphony Technology Group Company

2010-2013   Director, Global Market Access Communications  United BioSource Corporation

1999-2010   Associate Director   Total Healthcare Group

← Back to Our Board